Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival

Published:2022-10-21 Issue:39 Volume:28 Page:5750-5763
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Weingarden Alexa R,Gubatan John,Singh Sundeep,Balabanis Tatiana Clorice,Patel Akshar,Sharma Arpita,Habtezion Aida

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference34 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

3. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

4. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

5. Pembrolizumab for Early Triple-Negative Breast Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of immune checkpoint inhibitor-associated colitis treated with infliximab;Okayama Igakkai Zasshi (Journal of Okayama Medical Association);2024-08-01

4. Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis;Journal of Cancer;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP